rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

R. Erik Holmlin

President and CEO

Company insider

Files Form 4 as: President and CEO, Bionano Genomics; Director, Nanosphere.

In numbers

Trades disclosed
34
Buys
3
Sells
0
Bought
$40K
Sold
$0
Companies
2
Companies where not an officer
1
First trade
20 Jun 2013
Last trade
17 Feb 2026
Last filed
18 Feb 2026

Companies traded

Where they are an officer
BNGO Bionano GenomicsDirector, Officer · Life-science tools · last 17 Feb 20263 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
NanosphereDirector · last 30 Jun 20160 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Feb 2026filed 18 Feb 2026BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Code F$5651 at $1.10filing
17 Feb 2026filed 18 Feb 2026BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Code F$5651 at $1.10filing
2 Feb 2026filed 4 Feb 2026BNGO Bionano Genomicsoption or derivative · Life-science toolsSEC FORM 4 Code A—69,484 at $0.00filing
2 Feb 2026filed 4 Feb 2026BNGO Bionano Genomicsoption or derivative · Life-science toolsSEC FORM 4 Code A—69,484 at $0.00filing
3 Jun 2025filed 3 Jun 2025BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Code F$27775 at $3.69filing
14 Mar 2025filed 18 Mar 2025BNGO Bionano Genomicsoption or derivative · Life-science toolsSEC FORM 4 Code A—17,449 at $0.00filing
14 Mar 2025filed 18 Mar 2025BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Code F$687198 at $3.47filing
15 Feb 2025filed 19 Feb 2025BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Code F$29251 at $5.73filing
3 Jun 2024filed 5 Jun 2024BNGO Bionano Genomicsoption or derivative · Life-science toolsSEC FORM 4 Code A—204,000 at $0.00filing
3 Jun 2024filed 5 Jun 2024BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Code A—44,000 at $0.00filing
15 Feb 2024filed 5 Mar 2024BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Code F$3,9033,073 at $1.27filing
16 May 2023filed 16 May 2023BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Bought$9,60015,000 at $0.64filing
12 May 2023filed 16 May 2023BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Code F$33K50,141 at $0.66filing
15 Feb 2023filed 17 Feb 2023BNGO Bionano Genomicsoption or derivative · Life-science toolsSEC FORM 4 Code A—1,400,000 at $0.00filing
15 Feb 2023filed 17 Feb 2023BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Code A—300,000 at $0.00filing
12 May 2022filed 16 May 2022BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Code F$71K50,141 at $1.41filing
15 Feb 2022filed 15 Feb 2022BNGO Bionano Genomicsoption or derivative · Life-science toolsSEC FORM 4 Code A—1,400,000 at $0.00filing
29 Nov 2021filed 1 Dec 2021BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Bought$8,7782,200 at $3.99filing
29 Nov 2021filed 1 Dec 2021BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Bought$11K2,675 at $3.99filing
29 Nov 2021filed 1 Dec 2021BNGO Bionano GenomicsLife-science toolsSEC FORM 4 Bought$597150 at $3.98filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Albert LudererInterim Chief Executive · Interim Chief Executive at Bionano Genomics, filing Form 4 there in the last year
Jonathan Dixon VGeneral Counsel · General Counsel at Bionano Genomics, filing Form 4 there in the last year
Mark AdamchakPrincipal Accounting Officer · Principal Accounting Officer at Bionano Genomics, filing Form 4 there in the last year
Alex Reid HastieChief Scientific Officer · Chief Scientific Officer at Bionano Genomics, filing Form 4 there in the last year
Mark OldakowskiChief Operating Officer · Chief Operating Officer at Bionano Genomics, filing Form 4 there in the last year